Phyteau
@phyteau
Developing a completely safe, new class of therapeutics for diabetes, obesity, NAFLD & related metabolic conditions. Startup. RebelBio 2017. Plug and Play 2019
ID: 25680016
http://www.phyteau.co/ 21-03-2009 14:39:40
627 Tweet
1,1K Followers
2,2K Following
Study: Prevalence of #Diabetes Expected to Increase by 59.7% in 2025 - #obesity main risk factor. pharmacytimes.com/view/study-pre… Pharmacy Times #T2D #bloodsugar #Type2Diabetes
American Diabetes Association advises against Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists drugs. Full Statement here: diabetesjournals.org/care/article/d… American Diabetes Association - DiabetesPro #Diabetes #GLP1 #T2D #obesity #weightloss American Diabetes Association #ADA